Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.

← The SEC Ephemeris: the whole map

Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. the following drug product: > Atazanavir Sulfate

In the graph: all 1 documents (3 pages).

Application: NDA 205508
Ticker: Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.
Product: the following drug product: > Atazanavir Sulfate
Disease area: Not yet classified
Response path: Not yet classified
Complete Response Letters: July 28, 2025

From FDA letters and SEC filings. Not investment or medical advice.

Group by

Build queue · replay at pipeline speed